GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Ballentine Partners LLC

Ballentine Partners LLC lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.4% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 7,189 shares of the company’s stock after purchasing an additional 559 shares during the period. Ballentine Partners LLC’s holdings in GE HealthCare Technologies were worth $675,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Pathway Financial Advisers LLC acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth about $25,000. BNP Paribas acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth about $30,000. Fred Alger Management LLC acquired a new stake in shares of GE HealthCare Technologies during the second quarter worth about $26,000. Annapolis Financial Services LLC increased its position in shares of GE HealthCare Technologies by 171.9% during the first quarter. Annapolis Financial Services LLC now owns 348 shares of the company’s stock worth $32,000 after purchasing an additional 220 shares in the last quarter. Finally, M&R Capital Management Inc. acquired a new stake in shares of GE HealthCare Technologies during the third quarter worth about $33,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $88.42 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.55. The stock’s 50 day moving average is $88.42 and its two-hundred day moving average is $83.43. The firm has a market capitalization of $40.38 billion, a PE ratio of 25.70, a P/E/G ratio of 3.34 and a beta of 1.18. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping the consensus estimate of $0.98 by $0.02. The business had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.92 EPS. Research analysts anticipate that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.49%.

Analyst Ratings Changes

A number of analysts have recently commented on GEHC shares. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Evercore ISI boosted their price target on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price target on the stock. Finally, Stifel Nicolaus boosted their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research report on Monday, September 30th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and an average target price of $94.23.

Insider Buying and Selling

In related news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.27% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.